The for-profit hospital operator said its results for the year ending Dec. 31, 2021, included a pre-tax gain of $406 million associated with the divestiture of five Miami-area hospitals, as well as stimulus funds totaling $205 million. In 2020, Tenet recorded grant income of $899 million.
For 2021, Tenet recorded operating revenues of $19.5 billion, up from $17.6 billion recorded in 2020. The revenue was largely driven by Tenet’s hospital segment, which recorded $15.9 billion in revenue for 2021, and Tenet’s ambulatory care segment, which recorded revenue of $742 million.
Tenet ended the 12-month period with an operating income of $2.9 billion, up from $2 billion recorded one year before.
After factoring in losses from discontinued operations and income-tax expenses, net income attributable to Tenet shareholders was $915 million for the year.
In the fourth quarter, taking into account stimulus grants, Tenet saw a net income of continuing operations of $250 million, compared with a net income of $414 million in the same period in 2020. Without stimulus funds in the fourth quarter of 2021, Tenet posted a net income of $153 million, compared to $89 million recorded the same period one year before.
In the quarter ending Dec. 31, Tenet posted revenue of $4.9 billion, down 1.2 percent from the same quarter one year before.
Tenet also said it plans to retire $700 million of 7.5 percent senior secured notes due in 2025. It expects to save about $53 million annually with the debt reduction.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
